Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

News

Stay Updated! In The World Of Investments!
Sensex 60048.47 163.11 (0.27%)

Shilpa Medicare Latest News

24

Sep, 2021

Shilpa Medicare ties up with Cadila Healthcare

Shilpa Medicare, via its wholly owned subsidiary, Shilpa Biologicals (SBPL), has entered into a definitive agreement with Cadila Healthcare (CHL) for production-supply of the ZyCov-D vaccine drug substance from its integrated B...

Read More

01

Sep, 2021

Shilpa Medicare moves up on getting DCGI approval for ‘2-Deoxy2-Glucose’

Shilpa Medicare is currently trading at Rs. 598.95, up by 22.40 points or 3.89% from its previous closing of Rs. 576.55 on the BSE.

The scrip opened at Rs. 566.0...

Read More

31

Aug, 2021

Shilpa Medicare gets DCGI approval for ‘2-Deoxy2-Glucose’

Shilpa Medicare has received Drugs Controller General of India (DCGI) approval for ‘2-Deoxy2-Glucose’ (Bulk & Oral Powder). The bulk is manufactured by Shilpa Medicare, API facility in Raichur,&#...

Read More

07

Aug, 2021

Shilpa Medicare informs about board meeting

Pursuant to the regulation 29 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Shilpa Medicare has informed that a meeting of the Board of Directors of the company will be held on Saturday...

Read More

28

Jul, 2021

Shilpa Medicare informs about updates

Shilpa Medicare has informed today about the receipt of confirmation of WHO-GENEVA approval for API, Tenofovir Disoproxil Fumarate, a medication used to treat chronic hepatitis B and to prevent and treat HIV/AIDS, u...

Read More

13

Jul, 2021

Shilpa Medicare gains on getting nod to transfer API Business to WOS

Shilpa Medicare is currently trading at Rs. 610.80, up by 7.70 points or 1.28% from its previous closing of Rs. 603.10 on the BSE.

The scrip opened at Rs. 609.00 and has t...

Read More

13

Jul, 2021

Shilpa Medicare gets nod to transfer API Business to WOS

Shilpa Medicare has received approval from Board of Directors for transfer of API Business of the Company consisting of Unit-1 and Unit-2 situated at Raichur, Karnataka by way of slump sale to a wholly Owned Subsidi...

Read More

26

Jun, 2021

Shilpa Medicare informs about annual secretarial compliance report

Pursuant to Regulation 24A of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015, read with CIR/CFD/CMD1/27/2019 dated February 8, 2019, Shilpa Medicare has informed that it enclosed the An...

Read More

25

Jun, 2021

Shilpa Medicare zooms on getting approval to manufacture, sale of 2-Deoxy-D-Glucose

Shilpa Medicare is currently trading at Rs. 567.85, up by 17.05 points or 3.10% from its previous closing of Rs. 550.80 on the BSE.

The scrip opened at Rs. 554.0...

Read More

25

Jun, 2021

Shilpa Medicare gets approval to manufacture, sale of 2-Deoxy-D-Glucose

Shilpa Medicare has received an in-principle approval from Defence Research & Development Organisation (DRDO) to manufacture and sale of 2-Deoxy-D-Glucose (2DG). 2DG has been given emergency approval by the ...

Read More

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback